While waiting for the Final clinical trial report to be...

While waiting for the Final clinical trial report to be published, not much sales activities is expected to achieve.

However, if I bring your attention to the item 9.2 of the current and previous 4C:
Estimates Product manufacturing and operating costs for Q3 was $44,000 and Q4 is $637,000. With actual manufacturing and operating costs for Q3 at $82,000.

This has given us a precursor that the management is planning a ramp up in production in the next quarter.

Why?

I think the answer is very obvious.